Dominican Republic Nutraceutical and Supplement Manufacturing 2026

The US dietary supplement and nutraceutical market exceeded $60 billion in 2024 and continues growing at 7–9% annually. DR free zone contract manufacturers serve US supplement brands with FDA-compliant production, CAFTA-DR 0% import duty, and 3-day delivery to Florida—the US supplement distribution hub. This guide covers the regulatory framework, manufacturing capabilities, and market opportunity for nutraceutical production in Dominican Republic free zones.

FDA Regulatory Framework: DSHEA

Dietary supplements in the US are regulated under the Dietary Supplement Health and Education Act (DSHEA, 1994) and FDA’s Current Good Manufacturing Practices (cGMP) for dietary supplements under 21 CFR Part 111. Key requirements for DR supplement manufacturers: (1) FDA Establishment Registration: biennial renewal under 21 CFR Part 1: required for all supplement manufacturers and packers; (2) 21 CFR Part 111 cGMP compliance: covers personnel, physical plant, equipment, production controls, laboratory operations, quality control, and recordkeeping; (3) Identity, purity, strength, and composition testing: required for each incoming ingredient and finished product batch; (4) Serious Adverse Event Reporting (SAER): mandatory reporting of serious adverse events within 15 days; (5) Structure/Function claims: must be notified to FDA within 30 days of first use.

CAFTA-DR Tariff Benefits

Dietary supplements (HS 2106.90) exported from DR to US under CAFTA-DR: 0% duty vs. MFN rate of 6.4%. For a US brand importing $10M/year in supplements from non-FTA sources, CAFTA-DR saves $640,000 annually. More significant: for encapsulated botanical extracts (HS 2106.90) and protein supplements (HS 2106.10), CAFTA-DR eliminates duties of 6.4–8.5%. With DR’s tropical botanical ingredient advantage (moringa, sea moss, guanábana extracts), origin-story marketing and duty elimination combine for strong competitive positioning.

Contract Manufacturing Capabilities

DR nutraceutical CMOs offer: Solid dosage forms: tablets (direct compression, wet granulation), capsules (hard gelatin and HPMC vegetarian), softgels (limited capacity), powder blends, sachet filling; Liquid forms: liquid-filled capsules, tinctures, syrups, ready-to-drink (limited—requires beverage-grade filling); Packaging: bottle filling and capping, blister packaging, pouch filling, label application, retail-ready carton insertion. Third-party testing partnerships: NSF International, USP (United States Pharmacopeia), Informed Sport, and Eurofins for certificate of analysis generation.

Tropical Ingredient Advantage

DR’s agricultural biodiversity provides unique ingredient sourcing opportunities for premium supplement brands: Moringa oleifera: DR is a growing moringa producer; leaf powder, extract, and oil for antioxidant/nutrient supplements; Sea moss (Chondrus crispus): Caribbean-harvested sea moss gel and powder; Guanábana (Soursop): leaf extract and fruit powder; Cacao theobromine: DR organic cacao nibs and powder for energy/mood supplements. “Made in Dominican Republic” supplement brands with authentic Caribbean ingredient provenance can command 20–40% retail price premium in the US natural products market.

EGS Supplement Manufacturing Program

EGS connects US supplement brands with DR FDA-registered CMOs for private label and contract manufacturing—coordinating 21 CFR Part 111 compliance setup, tropical ingredient sourcing, and CAFTA-DR origin documentation. Assess your supplement manufacturing opportunity.

Explore More: EGS Insights Hub | DR Manufacturing Sectors | Contact Our Team